Government Set To Reduce Prices Of Some Essential Drugs

The union government has decided to provide relief to the Indian patients and reduced prices of about 39 drugs including anti-cancer drugs, anti-diabetes, antiviral, antibacterial drugs, antiretroviral drugs, anti-TB drugs, and drugs used in Covid treatment. Additionally, Mansukh Mandaviya, Union Health and Family Welfare has launched the revised National List of Essential Medicines (NLEM) at an event by the Indian Council of Medical Analysis (ICMR), which is quite significant step for the Indian healthcare segment.

Teneligliptin, an anti-diabetes drug, common anti TB drugs like Bedaquiline and Delamanid, Ivermectin utilized in Covid therapy, and Rotavirus vaccine have been taken into price control, amongst others. Concerning the NLEM a senior authorities official stated, "Some of these drugs have been discontinued, new therapies and higher options have been launched. Due to this fact it was essential to delete them." ICMR working for a long time to increase value management on the medicines, while the consultants deleted 16 odd drugs from the record. However, not all-important drugs will come under price capping.

The Standing Nationwide Committee on Medicines, headed by Balram Bhargava, director-general of the Indian Council of Medical Analysis, short-listed the medicines 'ought to be accessible in ample numbers and warranted amount'. NITI Aayog finally determined the drugs that will be put below the worth management. The official statement added, "It is a departure from the present mechanism by which all important medicines robotically go below value management." The aforementioned committee was influenced by the World Well being Organisation's revised record of important medicines and took the decision.

This new list and price capping will essentially help the healthcare segment in India and ease common citizens. The Indian economy is now standing at a position that even if the recovery is gaining momentum, but the underprivileged section of the population is still trying to find ease. The price capping in the selected medicines is expected to heal that.